UArizona Researchers to Study Long COVID as Part of National Collaborative | Aegis
Researchers to Study Long COVID as Part of National Collaborative
Recovery from COVID-19 varies from person to person. Many people make a full recovery, but others continue to experience symptoms related to the infection or develop new symptoms over time.
Researchers are leading a statewide effort to study the long-term effects of COVID-19 as part of the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) initiative. The goals of RECOVER are to understand, treat and prevent post-acute sequelae of SARS-CoV-2 infection (PASC). Long COVID is a form of PASC and refers to symptoms that persist for weeks or months after the acute infection.
The adult observational study has enrolled 12,573 people across the nation, 753 in Arizona. The adult cohort has closed enrollment. Participants will continue to be followed for the next 1-2 years. The information gathered from study participants will continue to shape Long COVID research and will be instrumental in the search for treatments.
RECOVER Clinical Trials have begun, and we are enrolling people across Arizona! The trials are designed as platform protocols that allow researchers to study different interventions at the same time. For more information about the clinical trials please visit the RECOVER Clinical Trials webpage.
If you are interested in taking part in the RECOVER Clinical Trials, please email RECOVER-ClinTrials@arizona.edu and a study team member will contact you.